L38. How to treat primary vasculitis of the central nervous system

Presse Med. 2013 Apr;42(4 Pt 2):605-7. doi: 10.1016/j.lpm.2013.01.038. Epub 2013 Mar 1.

Authors

Christian Pagnoux¹, Hubert de Boysson

Affiliation

¹ Mount Sinai Hospital, University of Toronto, Division of Rheumatology, Department of Medicine, Toronto, ON, Canada. cpagnoux@mtsinai.on.ca

PMID: 23465297
DOI: 10.1016/j.lpm.2013.01.038

No abstract available

Publication types

Review

MeSH terms

Adrenal Cortex Hormones / adverse effects
Adrenal Cortex Hormones / therapeutic use*
Anti-Inflammatory Agents / adverse effects
Anti-Inflammatory Agents / therapeutic use*
Cyclophosphamide / adverse effects
Cyclophosphamide / therapeutic use*
Drug Therapy, Combination
Humans
Immunosuppressive Agents / administration & dosage
Immunosuppressive Agents / therapeutic use*
Long-Term Care
Neurologic Examination / drug effects
Platelet Aggregation Inhibitors / adverse effects
Platelet Aggregation Inhibitors / therapeutic use
Secondary Prevention
Survival Rate
Vasculitis, Central Nervous System / diagnosis
Vasculitis, Central Nervous System / drug therapy*
Vasculitis, Central Nervous System / mortality

Substances

Adrenal Cortex Hormones
Anti-Inflammatory Agents
Immunosuppressive Agents
Platelet Aggregation Inhibitors
Cyclophosphamide